GYRASE A MUTATIONS CORRELATES WITH SUSCEPTIBILITY TEST AND TREATMENT OUTCOMES AFTER LEVOFLOXACIN-BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION

(1) Division of Gastroenterology, Internal Medicine, NATIONAL TAIWAN UNIVERSITY HOSPITAL, Taipe

(2) Internal Medicine, E- DA Hospital and I-Shou University, Kaohsiung County, Taiwan, China

(3) Biological Science and Technology, E- DA Hospital and I-ShouUniversity, Kaohsiung County, Ta



This item was part of the New insights in H. pylori infection session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A47